June K Li

发表

Obesity, clinical, and genetic predictors for glycemic progression in Chinese patients with type 2 diabetes: A cohort study using the Hong Kong Diabetes Register and Hong Kong Diabetes Biobank

R. Ozaki, A. Kong, J. Chan, 2020, PLoS medicine.

Combined Use of a Fasting Plasma Glucose Concentration and HbA1c or Fructosamine Predicts the Likelihood of Having Diabetes in High-Risk Subjects

J. Chan, J. Chan, C. Cockram, 1998, Diabetes Care.

C-reactive protein and insulin resistance in subjects with thalassemia minor and a family history of diabetes.

M. Ng, J. Chan, W. So, 2002, Diabetes care.

Clinical Predictors and Long-term Impact of Acute Kidney Injury on Progression of Diabetic Kidney Disease in Chinese Patients with Type 2 Diabetes.

R. Ozaki, J. Chan, W. So, 2022, Diabetes.

Neurological manifestations in m.3243A>G-related disease triggered by metformin.

C. Ching, Han-Chih Hencher Lee, T. Tong, 2021, Journal of diabetes and its complications.

Antibodies to Glutamic Acid Decarboxylase in Young Chinese Diabetic Patients

M. Rowley, I. Mackay, J. Chan, 1998, Annals of clinical biochemistry.

Genetic variants of hepatocyte nuclear factor-1beta in Chinese young-onset diabetic patients with nephropathy.

M. Ng, J. Chan, W. So, 2003, Journal of diabetes and its complications.

High-density lipoprotein subclasses and cardiovascular disease and mortality in type 2 diabetes: analysis from the Hong Kong Diabetes Biobank

R. Ozaki, A. Kong, W. So, 2022, Cardiovascular Diabetology.

Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism.

C. Cockram, C. Chow, M. Chan, 2003, The Journal of clinical endocrinology and metabolism.

Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.

R. Ozaki, J. Chan, W. So, 2022, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Development of genome-wide polygenic risk scores for lipid traits and clinical applications for dyslipidemia, subclinical atherosclerosis, and diabetes cardiovascular complications among East Asians

R. Ozaki, A. Kong, J. Chan, 2021, Genome medicine.

Cardiovascular Protective Effects of Adjunctive Alternative Medicine (Salvia miltiorrhiza and Pueraria lobata) in High-Risk Hypertension

C. Szeto, K. Woo, K. Fung, 2013, Evidence-based complementary and alternative medicine : eCAM.

Effects of Structured Versus Usual Care on Renal Endpoint in Type 2 Diabetes: The SURE Study

J. Chan, W. So, M. Tsang, 2009, Diabetes Care.

Serum Bilirubin and Cardiovascular Risk Factors in a Chinese Population

J. Chan, J. Woo, C. Cockram, 1996, Journal of cardiovascular risk.

Identification of a Common Variant for Coronary Heart Disease at PDE1A Contributes to Individualized Treatment Goals and Risk Stratification of Cardiovascular Complications in Chinese Patients With Type 2 Diabetes

A. Keech, R. Ozaki, A. Kong, 2023, Diabetes care.

Familial early-onset type 2 diabetes in Chinese patients: obesity and genetics have more significant roles than autoimmunity.

I. Mackay, J. Chan, M. Ng, 2001, Diabetes care.

Plasma insulin, growth hormone, cortisol, and central obesity among young Chinese type 2 diabetic patients.

J. Chan, J. Critchley, C. Cockram, 1999, Diabetes care.

Mitochondrial DNA A3243G mutation in patients with early‐ or late‐onset type 2 diabetes mellitus in Hong Kong Chinese

J. Critchley, P. Smith, C. Cockram, 2000, Clinical endocrinology.

The effect of age on cardiovascular risk factors in Chinese women.

J. Woo, C. Cockram, C. Cockram, 1997, International journal of cardiology.